Global Infectious Vaccines Market Research Report 2024(Status and Outlook)
Report Overview
A vaccine is a medical product primarily designed to stimulate antibodies against an infectious disease which help to improve the immunity of the target body.
This report provides a deep insight into the global Infectious Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Infectious Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Infectious Vaccines market in any manner.
Global Infectious Vaccines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
CSL Limited (Australia)
Bavarian Nordic (Denmark)
GlaxoSmithKline plc. (U.K.)
Emergent Bio Solutions Inc. (U.S.)
MedImmune LLC (U.S.)
Johnson and Johnson (U.S.)
Novartis AG (Switzerland)
Merck and Company (U.S.)
Sanofi Pasteur (France)
Pfizer Inc. (U.S.)
Market Segmentation (by Type)
Preventive Vaccine
Therapeutic Vaccine
Market Segmentation (by Application)
Adults
Pediatrics
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Infectious Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
A vaccine is a medical product primarily designed to stimulate antibodies against an infectious disease which help to improve the immunity of the target body.
This report provides a deep insight into the global Infectious Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Infectious Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Infectious Vaccines market in any manner.
Global Infectious Vaccines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
CSL Limited (Australia)
Bavarian Nordic (Denmark)
GlaxoSmithKline plc. (U.K.)
Emergent Bio Solutions Inc. (U.S.)
MedImmune LLC (U.S.)
Johnson and Johnson (U.S.)
Novartis AG (Switzerland)
Merck and Company (U.S.)
Sanofi Pasteur (France)
Pfizer Inc. (U.S.)
Market Segmentation (by Type)
Preventive Vaccine
Therapeutic Vaccine
Market Segmentation (by Application)
Adults
Pediatrics
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Infectious Vaccines Market
- Overview of the regional outlook of the Infectious Vaccines Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Infectious Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Infectious Vaccines
1.2 Key Market Segments
1.2.1 Infectious Vaccines Segment by Type
1.2.2 Infectious Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFECTIOUS VACCINES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Infectious Vaccines Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Infectious Vaccines Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFECTIOUS VACCINES MARKET COMPETITIVE LANDSCAPE
3.1 Global Infectious Vaccines Sales by Manufacturers (2019-2024)
3.2 Global Infectious Vaccines Revenue Market Share by Manufacturers (2019-2024)
3.3 Infectious Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Infectious Vaccines Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Infectious Vaccines Sales Sites, Area Served, Product Type
3.6 Infectious Vaccines Market Competitive Situation and Trends
3.6.1 Infectious Vaccines Market Concentration Rate
3.6.2 Global 5 and 10 Largest Infectious Vaccines Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 INFECTIOUS VACCINES INDUSTRY CHAIN ANALYSIS
4.1 Infectious Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFECTIOUS VACCINES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 INFECTIOUS VACCINES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Infectious Vaccines Sales Market Share by Type (2019-2024)
6.3 Global Infectious Vaccines Market Size Market Share by Type (2019-2024)
6.4 Global Infectious Vaccines Price by Type (2019-2024)
7 INFECTIOUS VACCINES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Infectious Vaccines Market Sales by Application (2019-2024)
7.3 Global Infectious Vaccines Market Size (M USD) by Application (2019-2024)
7.4 Global Infectious Vaccines Sales Growth Rate by Application (2019-2024)
8 INFECTIOUS VACCINES MARKET SEGMENTATION BY REGION
8.1 Global Infectious Vaccines Sales by Region
8.1.1 Global Infectious Vaccines Sales by Region
8.1.2 Global Infectious Vaccines Sales Market Share by Region
8.2 North America
8.2.1 North America Infectious Vaccines Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Infectious Vaccines Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Infectious Vaccines Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Infectious Vaccines Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Infectious Vaccines Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 CSL Limited (Australia)
9.1.1 CSL Limited (Australia) Infectious Vaccines Basic Information
9.1.2 CSL Limited (Australia) Infectious Vaccines Product Overview
9.1.3 CSL Limited (Australia) Infectious Vaccines Product Market Performance
9.1.4 CSL Limited (Australia) Business Overview
9.1.5 CSL Limited (Australia) Infectious Vaccines SWOT Analysis
9.1.6 CSL Limited (Australia) Recent Developments
9.2 Bavarian Nordic (Denmark)
9.2.1 Bavarian Nordic (Denmark) Infectious Vaccines Basic Information
9.2.2 Bavarian Nordic (Denmark) Infectious Vaccines Product Overview
9.2.3 Bavarian Nordic (Denmark) Infectious Vaccines Product Market Performance
9.2.4 Bavarian Nordic (Denmark) Business Overview
9.2.5 Bavarian Nordic (Denmark) Infectious Vaccines SWOT Analysis
9.2.6 Bavarian Nordic (Denmark) Recent Developments
9.3 GlaxoSmithKline plc. (U.K.)
9.3.1 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Basic Information
9.3.2 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Product Overview
9.3.3 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Product Market Performance
9.3.4 GlaxoSmithKline plc. (U.K.) Infectious Vaccines SWOT Analysis
9.3.5 GlaxoSmithKline plc. (U.K.) Business Overview
9.3.6 GlaxoSmithKline plc. (U.K.) Recent Developments
9.4 Emergent Bio Solutions Inc. (U.S.)
9.4.1 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Basic Information
9.4.2 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Product Overview
9.4.3 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Product Market Performance
9.4.4 Emergent Bio Solutions Inc. (U.S.) Business Overview
9.4.5 Emergent Bio Solutions Inc. (U.S.) Recent Developments
9.5 MedImmune LLC (U.S.)
9.5.1 MedImmune LLC (U.S.) Infectious Vaccines Basic Information
9.5.2 MedImmune LLC (U.S.) Infectious Vaccines Product Overview
9.5.3 MedImmune LLC (U.S.) Infectious Vaccines Product Market Performance
9.5.4 MedImmune LLC (U.S.) Business Overview
9.5.5 MedImmune LLC (U.S.) Recent Developments
9.6 Johnson and Johnson (U.S.)
9.6.1 Johnson and Johnson (U.S.) Infectious Vaccines Basic Information
9.6.2 Johnson and Johnson (U.S.) Infectious Vaccines Product Overview
9.6.3 Johnson and Johnson (U.S.) Infectious Vaccines Product Market Performance
9.6.4 Johnson and Johnson (U.S.) Business Overview
9.6.5 Johnson and Johnson (U.S.) Recent Developments
9.7 Novartis AG (Switzerland)
9.7.1 Novartis AG (Switzerland) Infectious Vaccines Basic Information
9.7.2 Novartis AG (Switzerland) Infectious Vaccines Product Overview
9.7.3 Novartis AG (Switzerland) Infectious Vaccines Product Market Performance
9.7.4 Novartis AG (Switzerland) Business Overview
9.7.5 Novartis AG (Switzerland) Recent Developments
9.8 Merck and Company (U.S.)
9.8.1 Merck and Company (U.S.) Infectious Vaccines Basic Information
9.8.2 Merck and Company (U.S.) Infectious Vaccines Product Overview
9.8.3 Merck and Company (U.S.) Infectious Vaccines Product Market Performance
9.8.4 Merck and Company (U.S.) Business Overview
9.8.5 Merck and Company (U.S.) Recent Developments
9.9 Sanofi Pasteur (France)
9.9.1 Sanofi Pasteur (France) Infectious Vaccines Basic Information
9.9.2 Sanofi Pasteur (France) Infectious Vaccines Product Overview
9.9.3 Sanofi Pasteur (France) Infectious Vaccines Product Market Performance
9.9.4 Sanofi Pasteur (France) Business Overview
9.9.5 Sanofi Pasteur (France) Recent Developments
9.10 Pfizer Inc. (U.S.)
9.10.1 Pfizer Inc. (U.S.) Infectious Vaccines Basic Information
9.10.2 Pfizer Inc. (U.S.) Infectious Vaccines Product Overview
9.10.3 Pfizer Inc. (U.S.) Infectious Vaccines Product Market Performance
9.10.4 Pfizer Inc. (U.S.) Business Overview
9.10.5 Pfizer Inc. (U.S.) Recent Developments
10 INFECTIOUS VACCINES MARKET FORECAST BY REGION
10.1 Global Infectious Vaccines Market Size Forecast
10.2 Global Infectious Vaccines Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Infectious Vaccines Market Size Forecast by Country
10.2.3 Asia Pacific Infectious Vaccines Market Size Forecast by Region
10.2.4 South America Infectious Vaccines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Infectious Vaccines by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Infectious Vaccines Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Infectious Vaccines by Type (2025-2030)
11.1.2 Global Infectious Vaccines Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Infectious Vaccines by Type (2025-2030)
11.2 Global Infectious Vaccines Market Forecast by Application (2025-2030)
11.2.1 Global Infectious Vaccines Sales (Kilotons) Forecast by Application
11.2.2 Global Infectious Vaccines Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Infectious Vaccines
1.2 Key Market Segments
1.2.1 Infectious Vaccines Segment by Type
1.2.2 Infectious Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFECTIOUS VACCINES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Infectious Vaccines Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Infectious Vaccines Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFECTIOUS VACCINES MARKET COMPETITIVE LANDSCAPE
3.1 Global Infectious Vaccines Sales by Manufacturers (2019-2024)
3.2 Global Infectious Vaccines Revenue Market Share by Manufacturers (2019-2024)
3.3 Infectious Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Infectious Vaccines Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Infectious Vaccines Sales Sites, Area Served, Product Type
3.6 Infectious Vaccines Market Competitive Situation and Trends
3.6.1 Infectious Vaccines Market Concentration Rate
3.6.2 Global 5 and 10 Largest Infectious Vaccines Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 INFECTIOUS VACCINES INDUSTRY CHAIN ANALYSIS
4.1 Infectious Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFECTIOUS VACCINES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 INFECTIOUS VACCINES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Infectious Vaccines Sales Market Share by Type (2019-2024)
6.3 Global Infectious Vaccines Market Size Market Share by Type (2019-2024)
6.4 Global Infectious Vaccines Price by Type (2019-2024)
7 INFECTIOUS VACCINES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Infectious Vaccines Market Sales by Application (2019-2024)
7.3 Global Infectious Vaccines Market Size (M USD) by Application (2019-2024)
7.4 Global Infectious Vaccines Sales Growth Rate by Application (2019-2024)
8 INFECTIOUS VACCINES MARKET SEGMENTATION BY REGION
8.1 Global Infectious Vaccines Sales by Region
8.1.1 Global Infectious Vaccines Sales by Region
8.1.2 Global Infectious Vaccines Sales Market Share by Region
8.2 North America
8.2.1 North America Infectious Vaccines Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Infectious Vaccines Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Infectious Vaccines Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Infectious Vaccines Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Infectious Vaccines Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 CSL Limited (Australia)
9.1.1 CSL Limited (Australia) Infectious Vaccines Basic Information
9.1.2 CSL Limited (Australia) Infectious Vaccines Product Overview
9.1.3 CSL Limited (Australia) Infectious Vaccines Product Market Performance
9.1.4 CSL Limited (Australia) Business Overview
9.1.5 CSL Limited (Australia) Infectious Vaccines SWOT Analysis
9.1.6 CSL Limited (Australia) Recent Developments
9.2 Bavarian Nordic (Denmark)
9.2.1 Bavarian Nordic (Denmark) Infectious Vaccines Basic Information
9.2.2 Bavarian Nordic (Denmark) Infectious Vaccines Product Overview
9.2.3 Bavarian Nordic (Denmark) Infectious Vaccines Product Market Performance
9.2.4 Bavarian Nordic (Denmark) Business Overview
9.2.5 Bavarian Nordic (Denmark) Infectious Vaccines SWOT Analysis
9.2.6 Bavarian Nordic (Denmark) Recent Developments
9.3 GlaxoSmithKline plc. (U.K.)
9.3.1 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Basic Information
9.3.2 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Product Overview
9.3.3 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Product Market Performance
9.3.4 GlaxoSmithKline plc. (U.K.) Infectious Vaccines SWOT Analysis
9.3.5 GlaxoSmithKline plc. (U.K.) Business Overview
9.3.6 GlaxoSmithKline plc. (U.K.) Recent Developments
9.4 Emergent Bio Solutions Inc. (U.S.)
9.4.1 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Basic Information
9.4.2 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Product Overview
9.4.3 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Product Market Performance
9.4.4 Emergent Bio Solutions Inc. (U.S.) Business Overview
9.4.5 Emergent Bio Solutions Inc. (U.S.) Recent Developments
9.5 MedImmune LLC (U.S.)
9.5.1 MedImmune LLC (U.S.) Infectious Vaccines Basic Information
9.5.2 MedImmune LLC (U.S.) Infectious Vaccines Product Overview
9.5.3 MedImmune LLC (U.S.) Infectious Vaccines Product Market Performance
9.5.4 MedImmune LLC (U.S.) Business Overview
9.5.5 MedImmune LLC (U.S.) Recent Developments
9.6 Johnson and Johnson (U.S.)
9.6.1 Johnson and Johnson (U.S.) Infectious Vaccines Basic Information
9.6.2 Johnson and Johnson (U.S.) Infectious Vaccines Product Overview
9.6.3 Johnson and Johnson (U.S.) Infectious Vaccines Product Market Performance
9.6.4 Johnson and Johnson (U.S.) Business Overview
9.6.5 Johnson and Johnson (U.S.) Recent Developments
9.7 Novartis AG (Switzerland)
9.7.1 Novartis AG (Switzerland) Infectious Vaccines Basic Information
9.7.2 Novartis AG (Switzerland) Infectious Vaccines Product Overview
9.7.3 Novartis AG (Switzerland) Infectious Vaccines Product Market Performance
9.7.4 Novartis AG (Switzerland) Business Overview
9.7.5 Novartis AG (Switzerland) Recent Developments
9.8 Merck and Company (U.S.)
9.8.1 Merck and Company (U.S.) Infectious Vaccines Basic Information
9.8.2 Merck and Company (U.S.) Infectious Vaccines Product Overview
9.8.3 Merck and Company (U.S.) Infectious Vaccines Product Market Performance
9.8.4 Merck and Company (U.S.) Business Overview
9.8.5 Merck and Company (U.S.) Recent Developments
9.9 Sanofi Pasteur (France)
9.9.1 Sanofi Pasteur (France) Infectious Vaccines Basic Information
9.9.2 Sanofi Pasteur (France) Infectious Vaccines Product Overview
9.9.3 Sanofi Pasteur (France) Infectious Vaccines Product Market Performance
9.9.4 Sanofi Pasteur (France) Business Overview
9.9.5 Sanofi Pasteur (France) Recent Developments
9.10 Pfizer Inc. (U.S.)
9.10.1 Pfizer Inc. (U.S.) Infectious Vaccines Basic Information
9.10.2 Pfizer Inc. (U.S.) Infectious Vaccines Product Overview
9.10.3 Pfizer Inc. (U.S.) Infectious Vaccines Product Market Performance
9.10.4 Pfizer Inc. (U.S.) Business Overview
9.10.5 Pfizer Inc. (U.S.) Recent Developments
10 INFECTIOUS VACCINES MARKET FORECAST BY REGION
10.1 Global Infectious Vaccines Market Size Forecast
10.2 Global Infectious Vaccines Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Infectious Vaccines Market Size Forecast by Country
10.2.3 Asia Pacific Infectious Vaccines Market Size Forecast by Region
10.2.4 South America Infectious Vaccines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Infectious Vaccines by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Infectious Vaccines Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Infectious Vaccines by Type (2025-2030)
11.1.2 Global Infectious Vaccines Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Infectious Vaccines by Type (2025-2030)
11.2 Global Infectious Vaccines Market Forecast by Application (2025-2030)
11.2.1 Global Infectious Vaccines Sales (Kilotons) Forecast by Application
11.2.2 Global Infectious Vaccines Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Infectious Vaccines Market Size Comparison by Region (M USD)
Table 5. Global Infectious Vaccines Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Infectious Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Infectious Vaccines Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Infectious Vaccines Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Vaccines as of 2022)
Table 10. Global Market Infectious Vaccines Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Infectious Vaccines Sales Sites and Area Served
Table 12. Manufacturers Infectious Vaccines Product Type
Table 13. Global Infectious Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Infectious Vaccines
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Infectious Vaccines Market Challenges
Table 22. Global Infectious Vaccines Sales by Type (Kilotons)
Table 23. Global Infectious Vaccines Market Size by Type (M USD)
Table 24. Global Infectious Vaccines Sales (Kilotons) by Type (2019-2024)
Table 25. Global Infectious Vaccines Sales Market Share by Type (2019-2024)
Table 26. Global Infectious Vaccines Market Size (M USD) by Type (2019-2024)
Table 27. Global Infectious Vaccines Market Size Share by Type (2019-2024)
Table 28. Global Infectious Vaccines Price (USD/Ton) by Type (2019-2024)
Table 29. Global Infectious Vaccines Sales (Kilotons) by Application
Table 30. Global Infectious Vaccines Market Size by Application
Table 31. Global Infectious Vaccines Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Infectious Vaccines Sales Market Share by Application (2019-2024)
Table 33. Global Infectious Vaccines Sales by Application (2019-2024) & (M USD)
Table 34. Global Infectious Vaccines Market Share by Application (2019-2024)
Table 35. Global Infectious Vaccines Sales Growth Rate by Application (2019-2024)
Table 36. Global Infectious Vaccines Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Infectious Vaccines Sales Market Share by Region (2019-2024)
Table 38. North America Infectious Vaccines Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Infectious Vaccines Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Infectious Vaccines Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Infectious Vaccines Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Infectious Vaccines Sales by Region (2019-2024) & (Kilotons)
Table 43. CSL Limited (Australia) Infectious Vaccines Basic Information
Table 44. CSL Limited (Australia) Infectious Vaccines Product Overview
Table 45. CSL Limited (Australia) Infectious Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. CSL Limited (Australia) Business Overview
Table 47. CSL Limited (Australia) Infectious Vaccines SWOT Analysis
Table 48. CSL Limited (Australia) Recent Developments
Table 49. Bavarian Nordic (Denmark) Infectious Vaccines Basic Information
Table 50. Bavarian Nordic (Denmark) Infectious Vaccines Product Overview
Table 51. Bavarian Nordic (Denmark) Infectious Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Bavarian Nordic (Denmark) Business Overview
Table 53. Bavarian Nordic (Denmark) Infectious Vaccines SWOT Analysis
Table 54. Bavarian Nordic (Denmark) Recent Developments
Table 55. GlaxoSmithKline plc. (U.K.) Infectious Vaccines Basic Information
Table 56. GlaxoSmithKline plc. (U.K.) Infectious Vaccines Product Overview
Table 57. GlaxoSmithKline plc. (U.K.) Infectious Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. GlaxoSmithKline plc. (U.K.) Infectious Vaccines SWOT Analysis
Table 59. GlaxoSmithKline plc. (U.K.) Business Overview
Table 60. GlaxoSmithKline plc. (U.K.) Recent Developments
Table 61. Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Basic Information
Table 62. Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Product Overview
Table 63. Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Emergent Bio Solutions Inc. (U.S.) Business Overview
Table 65. Emergent Bio Solutions Inc. (U.S.) Recent Developments
Table 66. MedImmune LLC (U.S.) Infectious Vaccines Basic Information
Table 67. MedImmune LLC (U.S.) Infectious Vaccines Product Overview
Table 68. MedImmune LLC (U.S.) Infectious Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. MedImmune LLC (U.S.) Business Overview
Table 70. MedImmune LLC (U.S.) Recent Developments
Table 71. Johnson and Johnson (U.S.) Infectious Vaccines Basic Information
Table 72. Johnson and Johnson (U.S.) Infectious Vaccines Product Overview
Table 73. Johnson and Johnson (U.S.) Infectious Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Johnson and Johnson (U.S.) Business Overview
Table 75. Johnson and Johnson (U.S.) Recent Developments
Table 76. Novartis AG (Switzerland) Infectious Vaccines Basic Information
Table 77. Novartis AG (Switzerland) Infectious Vaccines Product Overview
Table 78. Novartis AG (Switzerland) Infectious Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Novartis AG (Switzerland) Business Overview
Table 80. Novartis AG (Switzerland) Recent Developments
Table 81. Merck and Company (U.S.) Infectious Vaccines Basic Information
Table 82. Merck and Company (U.S.) Infectious Vaccines Product Overview
Table 83. Merck and Company (U.S.) Infectious Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Merck and Company (U.S.) Business Overview
Table 85. Merck and Company (U.S.) Recent Developments
Table 86. Sanofi Pasteur (France) Infectious Vaccines Basic Information
Table 87. Sanofi Pasteur (France) Infectious Vaccines Product Overview
Table 88. Sanofi Pasteur (France) Infectious Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Sanofi Pasteur (France) Business Overview
Table 90. Sanofi Pasteur (France) Recent Developments
Table 91. Pfizer Inc. (U.S.) Infectious Vaccines Basic Information
Table 92. Pfizer Inc. (U.S.) Infectious Vaccines Product Overview
Table 93. Pfizer Inc. (U.S.) Infectious Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Pfizer Inc. (U.S.) Business Overview
Table 95. Pfizer Inc. (U.S.) Recent Developments
Table 96. Global Infectious Vaccines Sales Forecast by Region (2025-2030) & (Kilotons)
Table 97. Global Infectious Vaccines Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Infectious Vaccines Sales Forecast by Country (2025-2030) & (Kilotons)
Table 99. North America Infectious Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Infectious Vaccines Sales Forecast by Country (2025-2030) & (Kilotons)
Table 101. Europe Infectious Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Infectious Vaccines Sales Forecast by Region (2025-2030) & (Kilotons)
Table 103. Asia Pacific Infectious Vaccines Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Infectious Vaccines Sales Forecast by Country (2025-2030) & (Kilotons)
Table 105. South America Infectious Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Infectious Vaccines Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Infectious Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Infectious Vaccines Sales Forecast by Type (2025-2030) & (Kilotons)
Table 109. Global Infectious Vaccines Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Infectious Vaccines Price Forecast by Type (2025-2030) & (USD/Ton)
Table 111. Global Infectious Vaccines Sales (Kilotons) Forecast by Application (2025-2030)
Table 112. Global Infectious Vaccines Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Infectious Vaccines Market Size Comparison by Region (M USD)
Table 5. Global Infectious Vaccines Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Infectious Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Infectious Vaccines Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Infectious Vaccines Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Vaccines as of 2022)
Table 10. Global Market Infectious Vaccines Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Infectious Vaccines Sales Sites and Area Served
Table 12. Manufacturers Infectious Vaccines Product Type
Table 13. Global Infectious Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Infectious Vaccines
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Infectious Vaccines Market Challenges
Table 22. Global Infectious Vaccines Sales by Type (Kilotons)
Table 23. Global Infectious Vaccines Market Size by Type (M USD)
Table 24. Global Infectious Vaccines Sales (Kilotons) by Type (2019-2024)
Table 25. Global Infectious Vaccines Sales Market Share by Type (2019-2024)
Table 26. Global Infectious Vaccines Market Size (M USD) by Type (2019-2024)
Table 27. Global Infectious Vaccines Market Size Share by Type (2019-2024)
Table 28. Global Infectious Vaccines Price (USD/Ton) by Type (2019-2024)
Table 29. Global Infectious Vaccines Sales (Kilotons) by Application
Table 30. Global Infectious Vaccines Market Size by Application
Table 31. Global Infectious Vaccines Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Infectious Vaccines Sales Market Share by Application (2019-2024)
Table 33. Global Infectious Vaccines Sales by Application (2019-2024) & (M USD)
Table 34. Global Infectious Vaccines Market Share by Application (2019-2024)
Table 35. Global Infectious Vaccines Sales Growth Rate by Application (2019-2024)
Table 36. Global Infectious Vaccines Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Infectious Vaccines Sales Market Share by Region (2019-2024)
Table 38. North America Infectious Vaccines Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Infectious Vaccines Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Infectious Vaccines Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Infectious Vaccines Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Infectious Vaccines Sales by Region (2019-2024) & (Kilotons)
Table 43. CSL Limited (Australia) Infectious Vaccines Basic Information
Table 44. CSL Limited (Australia) Infectious Vaccines Product Overview
Table 45. CSL Limited (Australia) Infectious Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. CSL Limited (Australia) Business Overview
Table 47. CSL Limited (Australia) Infectious Vaccines SWOT Analysis
Table 48. CSL Limited (Australia) Recent Developments
Table 49. Bavarian Nordic (Denmark) Infectious Vaccines Basic Information
Table 50. Bavarian Nordic (Denmark) Infectious Vaccines Product Overview
Table 51. Bavarian Nordic (Denmark) Infectious Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Bavarian Nordic (Denmark) Business Overview
Table 53. Bavarian Nordic (Denmark) Infectious Vaccines SWOT Analysis
Table 54. Bavarian Nordic (Denmark) Recent Developments
Table 55. GlaxoSmithKline plc. (U.K.) Infectious Vaccines Basic Information
Table 56. GlaxoSmithKline plc. (U.K.) Infectious Vaccines Product Overview
Table 57. GlaxoSmithKline plc. (U.K.) Infectious Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. GlaxoSmithKline plc. (U.K.) Infectious Vaccines SWOT Analysis
Table 59. GlaxoSmithKline plc. (U.K.) Business Overview
Table 60. GlaxoSmithKline plc. (U.K.) Recent Developments
Table 61. Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Basic Information
Table 62. Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Product Overview
Table 63. Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Emergent Bio Solutions Inc. (U.S.) Business Overview
Table 65. Emergent Bio Solutions Inc. (U.S.) Recent Developments
Table 66. MedImmune LLC (U.S.) Infectious Vaccines Basic Information
Table 67. MedImmune LLC (U.S.) Infectious Vaccines Product Overview
Table 68. MedImmune LLC (U.S.) Infectious Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. MedImmune LLC (U.S.) Business Overview
Table 70. MedImmune LLC (U.S.) Recent Developments
Table 71. Johnson and Johnson (U.S.) Infectious Vaccines Basic Information
Table 72. Johnson and Johnson (U.S.) Infectious Vaccines Product Overview
Table 73. Johnson and Johnson (U.S.) Infectious Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Johnson and Johnson (U.S.) Business Overview
Table 75. Johnson and Johnson (U.S.) Recent Developments
Table 76. Novartis AG (Switzerland) Infectious Vaccines Basic Information
Table 77. Novartis AG (Switzerland) Infectious Vaccines Product Overview
Table 78. Novartis AG (Switzerland) Infectious Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Novartis AG (Switzerland) Business Overview
Table 80. Novartis AG (Switzerland) Recent Developments
Table 81. Merck and Company (U.S.) Infectious Vaccines Basic Information
Table 82. Merck and Company (U.S.) Infectious Vaccines Product Overview
Table 83. Merck and Company (U.S.) Infectious Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Merck and Company (U.S.) Business Overview
Table 85. Merck and Company (U.S.) Recent Developments
Table 86. Sanofi Pasteur (France) Infectious Vaccines Basic Information
Table 87. Sanofi Pasteur (France) Infectious Vaccines Product Overview
Table 88. Sanofi Pasteur (France) Infectious Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Sanofi Pasteur (France) Business Overview
Table 90. Sanofi Pasteur (France) Recent Developments
Table 91. Pfizer Inc. (U.S.) Infectious Vaccines Basic Information
Table 92. Pfizer Inc. (U.S.) Infectious Vaccines Product Overview
Table 93. Pfizer Inc. (U.S.) Infectious Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Pfizer Inc. (U.S.) Business Overview
Table 95. Pfizer Inc. (U.S.) Recent Developments
Table 96. Global Infectious Vaccines Sales Forecast by Region (2025-2030) & (Kilotons)
Table 97. Global Infectious Vaccines Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Infectious Vaccines Sales Forecast by Country (2025-2030) & (Kilotons)
Table 99. North America Infectious Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Infectious Vaccines Sales Forecast by Country (2025-2030) & (Kilotons)
Table 101. Europe Infectious Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Infectious Vaccines Sales Forecast by Region (2025-2030) & (Kilotons)
Table 103. Asia Pacific Infectious Vaccines Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Infectious Vaccines Sales Forecast by Country (2025-2030) & (Kilotons)
Table 105. South America Infectious Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Infectious Vaccines Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Infectious Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Infectious Vaccines Sales Forecast by Type (2025-2030) & (Kilotons)
Table 109. Global Infectious Vaccines Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Infectious Vaccines Price Forecast by Type (2025-2030) & (USD/Ton)
Table 111. Global Infectious Vaccines Sales (Kilotons) Forecast by Application (2025-2030)
Table 112. Global Infectious Vaccines Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Infectious Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Infectious Vaccines Market Size (M USD), 2019-2030
Figure 5. Global Infectious Vaccines Market Size (M USD) (2019-2030)
Figure 6. Global Infectious Vaccines Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Infectious Vaccines Market Size by Country (M USD)
Figure 11. Infectious Vaccines Sales Share by Manufacturers in 2023
Figure 12. Global Infectious Vaccines Revenue Share by Manufacturers in 2023
Figure 13. Infectious Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Infectious Vaccines Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Infectious Vaccines Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Infectious Vaccines Market Share by Type
Figure 18. Sales Market Share of Infectious Vaccines by Type (2019-2024)
Figure 19. Sales Market Share of Infectious Vaccines by Type in 2023
Figure 20. Market Size Share of Infectious Vaccines by Type (2019-2024)
Figure 21. Market Size Market Share of Infectious Vaccines by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Infectious Vaccines Market Share by Application
Figure 24. Global Infectious Vaccines Sales Market Share by Application (2019-2024)
Figure 25. Global Infectious Vaccines Sales Market Share by Application in 2023
Figure 26. Global Infectious Vaccines Market Share by Application (2019-2024)
Figure 27. Global Infectious Vaccines Market Share by Application in 2023
Figure 28. Global Infectious Vaccines Sales Growth Rate by Application (2019-2024)
Figure 29. Global Infectious Vaccines Sales Market Share by Region (2019-2024)
Figure 30. North America Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Infectious Vaccines Sales Market Share by Country in 2023
Figure 32. U.S. Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Infectious Vaccines Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Infectious Vaccines Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Infectious Vaccines Sales Market Share by Country in 2023
Figure 37. Germany Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Infectious Vaccines Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Infectious Vaccines Sales Market Share by Region in 2023
Figure 44. China Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Infectious Vaccines Sales and Growth Rate (Kilotons)
Figure 50. South America Infectious Vaccines Sales Market Share by Country in 2023
Figure 51. Brazil Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Infectious Vaccines Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Infectious Vaccines Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Infectious Vaccines Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Infectious Vaccines Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Infectious Vaccines Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Infectious Vaccines Market Share Forecast by Type (2025-2030)
Figure 65. Global Infectious Vaccines Sales Forecast by Application (2025-2030)
Figure 66. Global Infectious Vaccines Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Infectious Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Infectious Vaccines Market Size (M USD), 2019-2030
Figure 5. Global Infectious Vaccines Market Size (M USD) (2019-2030)
Figure 6. Global Infectious Vaccines Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Infectious Vaccines Market Size by Country (M USD)
Figure 11. Infectious Vaccines Sales Share by Manufacturers in 2023
Figure 12. Global Infectious Vaccines Revenue Share by Manufacturers in 2023
Figure 13. Infectious Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Infectious Vaccines Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Infectious Vaccines Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Infectious Vaccines Market Share by Type
Figure 18. Sales Market Share of Infectious Vaccines by Type (2019-2024)
Figure 19. Sales Market Share of Infectious Vaccines by Type in 2023
Figure 20. Market Size Share of Infectious Vaccines by Type (2019-2024)
Figure 21. Market Size Market Share of Infectious Vaccines by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Infectious Vaccines Market Share by Application
Figure 24. Global Infectious Vaccines Sales Market Share by Application (2019-2024)
Figure 25. Global Infectious Vaccines Sales Market Share by Application in 2023
Figure 26. Global Infectious Vaccines Market Share by Application (2019-2024)
Figure 27. Global Infectious Vaccines Market Share by Application in 2023
Figure 28. Global Infectious Vaccines Sales Growth Rate by Application (2019-2024)
Figure 29. Global Infectious Vaccines Sales Market Share by Region (2019-2024)
Figure 30. North America Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Infectious Vaccines Sales Market Share by Country in 2023
Figure 32. U.S. Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Infectious Vaccines Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Infectious Vaccines Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Infectious Vaccines Sales Market Share by Country in 2023
Figure 37. Germany Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Infectious Vaccines Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Infectious Vaccines Sales Market Share by Region in 2023
Figure 44. China Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Infectious Vaccines Sales and Growth Rate (Kilotons)
Figure 50. South America Infectious Vaccines Sales Market Share by Country in 2023
Figure 51. Brazil Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Infectious Vaccines Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Infectious Vaccines Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Infectious Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Infectious Vaccines Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Infectious Vaccines Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Infectious Vaccines Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Infectious Vaccines Market Share Forecast by Type (2025-2030)
Figure 65. Global Infectious Vaccines Sales Forecast by Application (2025-2030)
Figure 66. Global Infectious Vaccines Market Share Forecast by Application (2025-2030)
